Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03031210 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jun 1, 2024 to Jun 1, 2027v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary and study completion dates: Jun 1, 2022 to Jun 1, 2024v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary and study completion dates: Jun 1, 2020 to Jun 1, 2022v7
Show 5 earlier versionsHide 5 earlier versions
  1. Re-verified, no change to tracked fieldsv6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 1, 2017 to Jun 11, 2017
    • Site details revised
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Secondary endpoints revised (6)v3
  5. Start date: Mar 1, 2017 to May 1, 2017v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study will be to evaluate whether a twice-daily antibiotic regimen is non-inferior to a thrice-daily regimen for the treatment of non-severe community acquired pneumonia in children presenting at a paediatric Emergency Department (ED).
Trial Details
NCT Number NCT03031210
Lead Sponsor St. Justine's Hospital
Conditions
(from sponsor)		 Community-acquired Pneumonia
Related terms Community-Acquired Pneumonia
Enrollment 1,370 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov